Connect Biopharma Holdings Limited Cash Equivalents, at Carrying Value
Connect Biopharma Holdings Limited (CNTB) had Cash Equivalents, at Carrying Value of $13.40 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash Equivalents, at Carrying Value $13.40M.
- 2026-03-31: Cash Equivalents, at Carrying Value $15.90M.
- 2025-12-31: Cash Equivalents, at Carrying Value $21.40M.
- 2024-12-31: Cash Equivalents, at Carrying Value $3.00M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $13.40M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $15.90M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $21.40M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $3.00M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |